News Daily News MI Definitions in SCOT-HEART Prompt Outcry—Then Silence—on Twitter Shelley Wood September 19, 2019
News Conference News ESC 2019 Prasugrel Bests Ticagrelor in ACS Patients Heading to PCI: ISAR-REACT 5 Shelley Wood September 01, 2019
News Conference News ESC 2019 New ‘Chronic Coronary Syndrome’ Guidelines Stress There’s Nothing Stable About CAD Shelley Wood August 31, 2019
News Conference News ESC 2019 ESC 2019: Antiplatelets in Diabetes, CAD and A-fib, an ARNI in HFpEF, Staged Complete PCI, and More Shelley Wood August 22, 2019
News Daily News Best Strategy Questioned for NSTE ACS Patients With Prior CABG Shelley Wood August 05, 2019
News Daily News Adherence to US Physical Activity Guidance Flattens as Sedentary Time Creeps Up Shelley Wood July 26, 2019
News Daily News Baseline Ischemia Not Linked to 10-Year Events in Stable CAD: MASS II Analysis Shelley Wood July 23, 2019
News Daily News Burst Balloons With Sapien 3 Ultra Prompt ‘Urgent Field Safety Notice’ and Canadian Recall Shelley Wood July 22, 2019
News Daily News FDA Grants Cardiac MR Indication for Gadavist Contrast Injection Shelley Wood July 16, 2019
News Daily News Liberal IVC Filter Use Not Warranted in Severe Trauma Patients Shelley Wood July 08, 2019
News Daily News FDA: Class I Recall for IntraClude Intra-Aortic Occlusion Device Shelley Wood July 02, 2019
News Daily News New TAVR NCD a ‘Missed Opportunity’ to Align SAVR, TAVR Quality Shelley Wood June 27, 2019
News Daily News CMS Releases Final Decision Memo on Rules for TAVR Program Reimbursement Shelley Wood June 24, 2019
News Conference News TVT 2019 Vast Numbers of Severe Symptomatic AS Patients Untreated? A Plea and Some Pushback Shelley Wood June 14, 2019
News Features ESC Heart Failure 2019 At the ESC Heart Failure Congress, Some COAPT Converts—and Some Pushback Shelley Wood May 30, 2019
News Conference News ESC Heart Failure 2019 Steep Rise in PCI for Ischemic Heart Failure Seen in Sweden, but Survival Favors CABG Shelley Wood May 28, 2019
News Conference News EuroPCR 2019 TAVR’s Benefit Across ‘Spectrum of Risk’ Supports Paradigm Shifts, Says EuroPCR Statement Shelley Wood May 23, 2019